Polarization of ILC2s in Peripheral Blood Might Contribute to Immunosuppressive Microenvironment in Patients with Gastric Cancer

Overview

Journal J Immunol Res

Publisher Wiley

Specialty Allergy & Immunology

Date 2014 Apr 18

PMID 24741632

Citations 69

Authors

Qingli Bie

Pan Zhang

Zhaoliang Su

Dong Zheng

Xinyu Ying

Yumin Wu

Huijian Yang

Deyu Chen

Shengjun Wang

Huaxi Xu

Affiliations

Soon will be listed here.

Abstract

Newly identified nuocytes or group 2 innate lymphoid cells (ILC2s) play an important role in Th2 cell mediated immunity such as protective immune responses to helminth parasites, allergic asthma, and chronic rhinosinusitis. However, the contributions of ILC2s in the occurrence and development of cancer remain unknown. Our previous study found that there was a predominant Th2 phenotype in patients with gastric cancer. In this study, the ILC2s related genes or molecules in PBMC from patients with gastric cancer were measured, and the potential correlation between them was analyzed. The expression levels of RORα, GATA3, T1/ST2, IL-17RB, CRTH2, IL-33, IL-5, and IL-4 mRNA were significantly increased in patients, but no significant changes were found in ICOS, CD45, and IL-13 expression, and there was a positive correlation between RORα or IL-13 and other related factors, such as ICOS and CD45. The increased frequency of ILC2s was also found in PBMC of patients by flow cytometry. In addition, the mRNA of Arg1 and iNOS were also significantly increased in patients. These results suggested that there are polarized ILC2s in gastric cancer patients which might contribute to immunosuppressive microenvironment and closely related to the upregulation of MDSCs and M2 macrophages.

Citing Articles

Molecular Mechanism for Malignant Progression of Gastric Cancer Within the Tumor Microenvironment.

Matsuoka T, Yashiro M Int J Mol Sci. 2024; 25(21).

PMID: 39519285 PMC: 11546171. DOI: 10.3390/ijms252111735.

Bridging Chronic Inflammation and Digestive Cancer: The Critical Role of Innate Lymphoid Cells in Tumor Microenvironments.

Shen G, Wang Q, Li Z, Xie J, Han X, Wei Z Int J Biol Sci. 2024; 20(12):4799-4818.

PMID: 39309440 PMC: 11414386. DOI: 10.7150/ijbs.96338.

Unveiling the gastric microbiota: implications for gastric carcinogenesis, immune responses, and clinical prospects.

Liu Z, Zhang D, Chen S J Exp Clin Cancer Res. 2024; 43(1):118.

PMID: 38641815 PMC: 11027554. DOI: 10.1186/s13046-024-03034-7.

Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME).

Sadeghi M, Dehnavi S, Sharifat M, Amiri A, Khodadadi A Heliyon. 2024; 10(5):e27480.

PMID: 38463798 PMC: 10923864. DOI: 10.1016/j.heliyon.2024.e27480.

Interleukin-33 Expression on Treatment Outcomes and Prognosis in Brazilian Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Albuquerque R, Borba M, Fernandes M, Filgueira T, Martins D, Filho J Int J Mol Sci. 2023; 24(22).

PMID: 38003516 PMC: 10671081. DOI: 10.3390/ijms242216326.

References

Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View

Walker J, Barlow J, McKenzie A . Innate lymphoid cells--how did we miss them?. Nat Rev Immunol. 2013; 13(2):75-87. DOI: 10.1038/nri3349. View

Mjosberg J, Trifari S, Crellin N, Peters C, Van Drunen C, Piet B . Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011; 12(11):1055-62. DOI: 10.1038/ni.2104. View

Hoyler T, Klose C, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins E . The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity. 2012; 37(4):634-48. PMC: 3662874. DOI: 10.1016/j.immuni.2012.06.020. View

Saenz S, Noti M, Artis D . Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol. 2010; 31(11):407-13. DOI: 10.1016/j.it.2010.09.001. View

Wong S, Walker J, Jolin H, Drynan L, Hams E, Camelo A . Transcription factor RORα is critical for nuocyte development. Nat Immunol. 2012; 13(3):229-36. PMC: 3343633. DOI: 10.1038/ni.2208. View

Xu Y, Gao J, Su Z, Dai X, Li Y, Liu Y . Downregulation of Hlx closely related to the decreased expressions of T-bet and Runx3 in patients with gastric cancer may be associated with a pathological event leading to the imbalance of Th1/Th2. Clin Dev Immunol. 2012; 2012:949821. PMC: 3514004. DOI: 10.1155/2012/949821. View

Cunningham D, Allum W, Stenning S, Thompson J, van de Velde C, Nicolson M . Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355(1):11-20. DOI: 10.1056/NEJMoa055531. View

Bando J, Nussbaum J, Liang H, Locksley R . Type 2 innate lymphoid cells constitutively express arginase-I in the naive and inflamed lung. J Leukoc Biol. 2013; 94(5):877-84. PMC: 3800063. DOI: 10.1189/jlb.0213084. View

10.

Yang P, Qiu G, Su Z, Chen J, Wang S, Kong F . The mutations of Th1 cell-specific T-box transcription factor may be associated with a predominant Th2 phenotype in gastric cancers. Int J Immunogenet. 2010; 37(2):111-5. DOI: 10.1111/j.1744-313X.2010.00899.x. View

11.

Spits H, Artis D, Colonna M, Diefenbach A, Di Santo J, Eberl G . Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol. 2013; 13(2):145-9. DOI: 10.1038/nri3365. View

12.

Bronte V, Zanovello P . Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol. 2005; 5(8):641-54. DOI: 10.1038/nri1668. View

13.

Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T . Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun. 2009; 386(1):181-5. DOI: 10.1016/j.bbrc.2009.06.008. View

14.

Mjosberg J, Bernink J, Golebski K, Karrich J, Peters C, Blom B . The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity. 2012; 37(4):649-59. DOI: 10.1016/j.immuni.2012.08.015. View

15.

Rodriguez P, Ochoa A . Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev. 2008; 222:180-91. PMC: 3546504. DOI: 10.1111/j.1600-065X.2008.00608.x. View

16.

Monticelli L, Sonnenberg G, Abt M, Alenghat T, Ziegler C, Doering T . Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011; 12(11):1045-54. PMC: 3320042. DOI: 10.1031/ni.2131. View

17.

Khaled Y, Ammori B, Elkord E . Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol Cell Biol. 2013; 91(8):493-502. DOI: 10.1038/icb.2013.29. View

18.

Terabe M, Park J, Berzofsky J . Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Immunother. 2003; 53(2):79-85. PMC: 11034335. DOI: 10.1007/s00262-003-0445-0. View

19.

Whiteside T . The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008; 27(45):5904-12. PMC: 3689267. DOI: 10.1038/onc.2008.271. View

20.

Spits H, Cupedo T . Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012; 30:647-75. DOI: 10.1146/annurev-immunol-020711-075053. View